CARILLON TOWER ADVISERS, INC. - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 113 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
CARILLON TOWER ADVISERS, INC. ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$24,682,000
+16.6%
1,120,359
-4.8%
0.15%
-46.8%
Q3 2020$21,165,000
-25.6%
1,176,513
+5.0%
0.28%
+28.8%
Q2 2020$28,457,000
-99.9%
1,120,3590.0%0.22%
+15.3%
Q1 2020$19,415,821,000
-21.3%
1,120,3590.0%0.19%
+15.2%
Q4 2019$24,681,509,000
+153315.6%
1,120,3590.0%0.16%
+47.3%
Q3 2019$16,088,0001,120,3590.11%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 4,080,237$74,954,00012.68%
Aquilo Capital Management, LLC 1,237,379$22,731,0008.86%
EcoR1 Capital, LLC 3,346,301$61,472,0006.42%
RTW INVESTMENTS, LP 6,963,135$127,913,0005.51%
BRIDGER MANAGEMENT, LLC 1,679,344$30,850,0003.57%
Parkman Healthcare Partners LLC 300,805$5,526,0002.56%
ACUTA CAPITAL PARTNERS, LLC 256,500$4,712,0002.28%
Integral Health Asset Management, LLC 185,000$3,398,0001.50%
DAFNA Capital Management LLC 147,714$2,714,0001.13%
EAM Global Investors LLC 88,465$1,625,0000.95%
View complete list of DICERNA PHARMACEUTICALS INC shareholders